NHS England Pauses Cross-Sex Hormones for Under-18s - What It Means for Healthcare Stocks
NHS England has announced a pause on prescribing cross-sex hormones to individuals under the age of 18, a move that could have significant implications for pharmaceutical companies and heal…
